Arterial allografts in treating aortic graft infections: something old, something new.
Surgical treatment of major aortic infection remains the most demanding challenge in aortic surgery. Excellent results with cryopreserved allograft heart valves in the treatment of acute infectious endocarditis prompted the use of allografts for in situ replacement of mycotic aortic aneurysms and prosthetic aortic graft infection. This review summarizes the indications for use of allografts in the management of major aortic infection, describes technical pitfalls at the time of implantation, presents clinical results, and analyzes the findings in explanted segments of failed allografts. In addition, the current status of the use of allografts will be compared with competitive techniques for treatment of vascular infections.
Cardiovascular Centre Zurich, Hospital Im Park, Zürich, Switzerland. paul.vogt@hirslanden.ch
Paul R
PR
Vogt
D001011:Aorta / Q000601:surgery*; D001158:Arteries / Q000637:transplantation*; D001807:Blood Vessel Prosthesis / Q000009:adverse effects*; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects* / Q000295:instrumentation; D003428:Cross Infection / Q000175:diagnosis / Q000382:microbiology / Q000601:surgery*; D015925:Cryopreservation; D020878:Device Removal; D006801:Humans; D016459:Prosthesis-Related Infections / Q000175:diagnosis / Q000382:microbiology / Q000601:surgery*; D012008:Recurrence; D012086:Reoperation; D014184:Transplantation, Homologous; D016896:Treatment Outcome